KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medtronic (MDT) Change in Receivables (2016 - 2026)

Medtronic's Change in Receivables history spans 13 years, with the latest figure at -$13.0 million for Q1 2026.

  • For Q1 2026, Change in Receivables fell 533.33% year-over-year to -$13.0 million; the TTM value through Jan 2026 reached $162.0 million, down 62.76%, while the annual FY2025 figure was $433.0 million, 10.74% up from the prior year.
  • Change in Receivables for Q1 2026 was -$13.0 million at Medtronic, down from $214.0 million in the prior quarter.
  • Across five years, Change in Receivables topped out at $435.0 million in Q4 2022 and bottomed at -$288.0 million in Q3 2025.
  • The 5-year median for Change in Receivables is $62.0 million (2023), against an average of $95.2 million.
  • The largest annual shift saw Change in Receivables surged 232.06% in 2022 before it crashed 533.33% in 2026.
  • A 5-year view of Change in Receivables shows it stood at $435.0 million in 2022, then plummeted by 35.4% to $281.0 million in 2023, then rose by 3.56% to $291.0 million in 2024, then dropped by 26.46% to $214.0 million in 2025, then plummeted by 106.07% to -$13.0 million in 2026.
  • Per Business Quant, the three most recent readings for MDT's Change in Receivables are -$13.0 million (Q1 2026), $214.0 million (Q4 2025), and -$288.0 million (Q3 2025).